Exchange Capital Management’s Intercontinental Exchange ICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.49M Buy
8,132
+1,797
+28% +$309K 0.22% 105
2025
Q1
$1.09M Buy
6,335
+79
+1% +$12.9K 0.18% 118
2024
Q4
$932K Sell
6,256
-14
-0.2% -$2.22K 0.15% 125
2024
Q3
$1.01M Sell
6,270
-261
-4% -$40.2K 0.16% 126
2024
Q2
$894K Sell
6,531
-95
-1% -$12.8K 0.15% 132
2024
Q1
$911K Sell
6,626
-15
-0.2% -$1.99K 0.15% 135
2023
Q4
$853K Sell
6,641
-120
-2% -$13.6K 0.15% 124
2023
Q3
$744K Buy
6,761
+2,560
+61% +$293K 0.14% 129
2023
Q2
$475K Buy
+4,201
New +$455K 0.09% 139
2022
Q4
Sell
-2,258
Closed -$204K 163
2022
Q3
$204K Hold
2,258
0.05% 158
2022
Q2
$212K Hold
2,258
0.05% 155
2022
Q1
$298K Sell
2,258
-31
-1% -$4K 0.06% 151
2021
Q4
$313K Buy
+2,289
New +$303K 0.06% 154
2015
Q1
Sell
-110
Closed -$5K 192
2014
Q4
$5K Buy
+110
New +$4.71K ﹤0.01% 198

Other funds holding ICE

Exchange Capital Management's ICE Position: Q2 2025 in Review

Exchange Capital Management increased its Intercontinental Exchange (ICE) stake by 28% in Q2 2025, buying an estimated $309K and bringing the position to 8,132 shares worth $1.49M. The position accounts for 0.22% of the portfolio, ranked #105.

Exchange Capital Management first reported a position in ICE in Q4 2014 and has held it in 14 quarters since. 1,705 funds tracked by Wall St. Rank hold ICE as of Q2 2025.

  • Exchange Capital Management held 8,132 shares of Intercontinental Exchange worth $1.49M as of Q2 2025.
  • Exchange Capital Management bought 1,797 Intercontinental Exchange shares in Q2 2025, an estimated $309K.
  • Intercontinental Exchange made up 0.22% of Exchange Capital Management's portfolio in Q2 2025, its #105 holding.
  • Exchange Capital Management first reported a position in Intercontinental Exchange in Q4 2014 and has held it in 14 quarters since.
  • 1,705 funds tracked by Wall St. Rank held Intercontinental Exchange as of Q2 2025.

Based on Exchange Capital Management's 13F filing for Q2 2025, filed 21 Jul 2025.